Clinical Trial Update: Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary Angioplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether B-type natriuretic peptide (BNP) reduces endothelial dysfunction after coronary angioplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BNP (b-type natriuretic peptide)

Snippet

Sponsor: The Baruch Padeh Medical Center, Poriya | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN